Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1.

MLA

Shiba, Naoko, et al. “Efficacy of Exon-Skipping Therapy for DMD Cardiomyopathy with Mutations in Actin Binding Domain 1.” Molecular Therapy. Nucleic Acids, vol. 34, Oct. 2023, p. 102060. EBSCOhost, https://doi.org/10.1016/j.omtn.2023.102060.

APA

Shiba, N., Yang, X., Sato, M., Kadota, S., Suzuki, Y., Agata, M., Nagamine, K., Izumi, M., Honda, Y., Koganehira, T., Kobayashi, H., Ichimura, H., Chuma, S., Nakai, J., Tohyama, S., Fukuda, K., Miyazaki, D., Nakamura, A., & Shiba, Y. (2023). Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1. Molecular Therapy. Nucleic Acids, 34, 102060. https://doi.org/10.1016/j.omtn.2023.102060

Chicago

Shiba, Naoko, Xiao Yang, Mitsuto Sato, Shin Kadota, Yota Suzuki, Masahiro Agata, Kohei Nagamine, et al. 2023. “Efficacy of Exon-Skipping Therapy for DMD Cardiomyopathy with Mutations in Actin Binding Domain 1.” Molecular Therapy. Nucleic Acids 34 (October): 102060. doi:10.1016/j.omtn.2023.102060.